This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4r6a
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ''' | + | ==Crystal structure of human TLR8 in complex with Hybrid-2== |
| - | + | <StructureSection load='4r6a' size='340' side='right' caption='[[4r6a]], [[Resolution|resolution]] 2.10Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[4r6a]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R6A OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4R6A FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=HB2:1-(4-AMINO-2-BUTYL-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL)-2-METHYLPROPAN-2-OL'>HB2</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4r6a FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r6a OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4r6a RCSB], [http://www.ebi.ac.uk/pdbsum/4r6a PDBsum]</span></td></tr> | |
| - | + | </table> | |
| - | [[ | + | == Function == |
| - | [[ | + | [[http://www.uniprot.org/uniprot/TLR8_HUMAN TLR8_HUMAN]] Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response.<ref>PMID:17932028</ref> |
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
[[Category: Ohto, U]] | [[Category: Ohto, U]] | ||
[[Category: Shimizu, T]] | [[Category: Shimizu, T]] | ||
| + | [[Category: Tanji, H]] | ||
| + | [[Category: Antiviral and antitumor drug binding]] | ||
| + | [[Category: Glycosylation]] | ||
| + | [[Category: Innate immunity]] | ||
| + | [[Category: Leucine rich repeat]] | ||
| + | [[Category: Rna binding protein]] | ||
| + | [[Category: Rna receptor]] | ||
| + | [[Category: Rna recognition]] | ||
| + | [[Category: Secreted]] | ||
| + | [[Category: Ssrna]] | ||
| + | [[Category: Structure-based ligand design]] | ||
| + | [[Category: Vaccine adjuvant]] | ||
Revision as of 13:32, 26 August 2015
Crystal structure of human TLR8 in complex with Hybrid-2
| |||||||||||
